Stanford Masters chats with Moneycontrol's Viswanath Pilla to find out the reason behind the rising OAI and the effect they will have on pharma companies.
Official Action Indicated (OAI) is one of the classifications issued by the US Food and Drug Administration (USFDA) after inspection.
OAI means USFDA doesn't hold the manufacturing facility upto standard and will take official action.Last year Indian pharma companies had received 14 OAIs but this year the companies have already received more than 12 OAIs, Stanford Masters chats with Moneycontrol's Viswanath Pilla to find out the reason behind this.The Great Diwali Discount!
Unlock 75% more savings this festive season. Get Moneycontrol Pro for a year for Rs 289 only.
Coupon code: DIWALI. Offer valid till 10th November, 2019 .